Dermatofibrom
Begutachtet von Dr Toni Hazell, MRCGPZuletzt aktualisiert von Dr Rosalyn Adleman, MRCGPLast updated 14. März 2025
Erfüllt die Anforderungen des Patienten Richtlinien des Patienten
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
Medizinische Fachkräfte
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our Gesundheitsartikel more useful.
In diesem Artikel:
Synonym: fibrous histiocytoma
Lesen Sie unten weiter
What are dermatofibromas?
Dermatofibromas are common and benign skin tumours but frequently cause concern upon discovery.
Causes of dermatofibromas (aetiology)
Zurück zum InhaltTraditionally, dermatofibromas were attributed to a reaction to trauma such as insect bites. However, the precise aetiology is unclear. Some believe them to be benign neoplasms rather than reactive in origin.
The most common dermatofibromas contain a mixture of fibroblasts, macrophages and blood vessels. Most involve the dermis and may extend to the subcutis. A number of less common variants where the histology differs, such as the aneurysmal fibrous histiocytoma, hemosiderotic fibrous histiocytoma, cellular fibrous histiocytoma and epithelioid fibrous histiocytoma, have been described.1 Different types are associated with different behaviours and outcomes.
Lesen Sie unten weiter
How common are dermatofibromas? (Epidemiology) 23
Zurück zum InhaltThey are common but determining global incidence is challenging as most patients are asymptomatic and do not seek medical attention.
They are more frequent in women than in men.
They can occur at any age, most commonly in young adulthood.
They occur in all ethnicities.
They are more common and more numerous in those with immunosuppression.
Symptoms of dermatofibromas (presentation)3 4
Zurück zum InhaltDermatofibromas are usually single nodules that develop on an extremity, most commonly the lower legs. They are freely moving, firm-to-hard nodules of 0.5-1.0 cm diameter.
The skin's surface is generally smooth, occasionally scaly. The overlying skin may be tethered, causing it to dimple when pinched. The skin colour varies from skin-coloured to pink/red to cream/white to brown.
Dermatofibromas can occur at jeglicher skin site and individuals may have several lesions (up to 15).
Multiple variants tend to occur where immunity is impaired (eg, autoimmune disease, systemic lupus erythematosus, HIV, leukaemia).
The nodule is usually asymptomatic but can be itchy or tender.
After initial growth, they tend to remain static in size.
Dermatofibroma - close-up view

© Mohammad2018, CC BY-SA 4.0, über Wikimedia Commons
Lesen Sie unten weiter
Diagnosis of dermatofibromas
Zurück zum InhaltDiagnosis is usually straightforward provided you palpate the lesion, as few other skin lesions are as firm.
The pinch test is helpful (but not definitive): squeezing the lesion from the sides results in dimpling of overlying skin.
With a dermatoscope, dermatofibromas typically show a pigment network and central white patch but there is considerable variation.5 One study noted a difference in dermatoscopy appearance depending on location of the lesion.6
Excision biopsy is useful where diagnostic uncertainty remains after examination.
Differentialdiagnose
Zurück zum InhaltBeinhaltet:
Keloid or hypertrophic scar.
Metastasiertes Karzinom der Haut.
Spitz' naevus.
Deep penetrating dermatofibromas may be difficult to distinguish, even histologically, from rare malignant fibrohistiocytic tumours - eg, dermatofibrosarcoma protuberans.7
Management of dermatofibromas
Zurück zum InhaltReassure - generally no treatment is required.
Remove where cosmetically disliked, symptomatic or there is diagnostic uncertainty. Note that there is a significant local recurrence rate.
Removal by elliptical excision or punch biopsy usually provides the most satisfactory results: shave excision or cryotherapy have higher risks of incomplete excision and recurrence.
A Dutch study showed about 2% of GP subcutis excisions yield unexpected or rare malignancies, and UK studies have shown a lack of reliability in GP diagnosis of skin malignancy.8 9 Therefore, even where excision is for cosmetic or symptomatic reasons, it is nonetheless worth sending specimens to histology.
Wann überweisen
Referral is normally indicated only for diagnostic uncertainty, to differentiate from other potentially harmful pigmented lesions.
Prognose
Zurück zum InhaltDermatofibromas are almost invariably benign - there are extremely rare case reports of metastasising cellular dermatofibromas, although histological distinction from other tumours can prove difficult.10 Follow up lesions that are histologically atypical or undergo recurrence.
Most are static and persist indefinitely although, uncommonly, they spontaneously regress.
The cellular type tends to become larger and, as above, has occasionally been reported to metastasise.
They may become repeatedly irritated - by shaving, for example.
Weiterführende Literatur und Referenzen
- Higgins JC, Maher MH, Douglas MS; Diagnose häufiger gutartiger Hauttumoren. Am Fam Physician. 2015 Okt 1;92(7):601-7.
- Marghoob AA, Usatine RP, Jaimes N; Dermoscopy for the family physician. Am Fam Physician. 2013 Oct 1;88(7):441-50.
- Myers DJ, Fillman EP; Dermatofibroma. StatPearls, Sept 2021.
- Dermatofibrom; DermIS.
- Alves JV, Matos DM, Barreiros HF, et al; Variants of dermatofibroma--a histopathological study. An Bras Dermatol. 2014 May-Jun;89(3):472-7.
- Myers DJ, Fillman EP. Dermatofibroma. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan
- Dermatofibrom; Gesellschaft für Dermatologie in der Primärversorgung
- Dermatofibrom; DermNet NZ
- Zaballos P, Puig S, Llambrich A, et al; Dermoscopy of dermatofibromas: a prospective morphological study of 412 cases. Arch Dermatol. 2008 Jan;144(1):75-83.
- Brancaccio G, Nuzzo T, Di Maio R, et al; Dermatofibroma looks dermoscopically different on trunk vs extremities. G Ital Dermatol Venereol. 2015 Dec 23.
- Hanly AJ, Jorda M, Elgart GW, et al; High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors. Arch Pathol Lab Med. 2006 Jun;130(6):831-4.
- Buis PA, Verweij W, van Diest PJ; Value of histopathologic analysis of subcutis excisions by general practitioners. BMC Fam Pract. 2007 Jan 26;8:5.
- George S, Pockney P, Primrose J, et al; A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial. Health Technol Assess. 2008 May;12(23):iii-iv, ix-38.
- Bandarchi B, Ma L, Marginean C, et al; D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. Mod Pathol. 2010 Mar;23(3):434-8. Epub 2010 Jan 8.
Lesen Sie unten weiter
Artikelverlauf
Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und begutachtet.
Nächste Überprüfung fällig: 13. März 2028
14. März 2025 | Neueste Version

Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.

Fühlen Sie sich unwohl?
Bewerten Sie Ihre Symptome online kostenlos